SCHEMBL24674904

SCHEMBL24674904

COC(=O)CCCOCCOCCOCCCCCCOCc1ccccc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.40
PPARG P37231 2/20 0.39
LTB4R Q15722 1/20 0.39
MAOB P27338 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.37
LMNA P02545 2/20 0.37
PPARA Q07869 1/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3166473 0.80 THRA (0.49) TSHRMAOBKDM4EALDH1A1HPGD
SCHEMBL26115850 0.79 EPHX2 (0.53) PPARGLTB4RKDM4EMAPTLMNA
SCHEMBL2669347 0.79 MAOB (0.43) TSHRLTB4RMAOBKDM4EMAPT
SCHEMBL8935206 0.76 CYP4F2 (0.49) TSHRMAPTLMNAALDH1A1HPGD
SCHEMBL24757124 0.76 LMNA (0.51) TSHRKDM4ELMNAALDH1A1
SCHEMBL25308442 0.76 EPHX2 (0.55) PPARGLTB4RKDM4EMAPTLMNA
SCHEMBL4109675 0.75 LMNA (0.54) TSHRKDM4ELMNAALDH1A1
SCHEMBL13948679 0.75 CYP4F2 (0.55) TSHRMAPTLMNAALDH1A1HPGD
SCHEMBL4846056 0.75 CHRM3 (0.44) TSHRMAOBKDM4EALDH1A1
SCHEMBL12147930 0.74 EPHX2 (0.53) LTB4RKDM4ELMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022159688-A9 DEGRADERS OF GRK2 AND USES THEREOF SONATA THERAPEUTICS, INC. (US) 2023-09-21 WO disclosed
WO-2023129564-A1 DEGRADERS OF GRK2 AND USES THEREOF CYGNAL THERAPEUTICS, INC. (US) 2023-07-06 WO disclosed
WO-2022159688-A1 DEGRADERS OF GRK2 AND USES THEREOF CYGNAL THERAPEUTICS, INC. (US) 2022-07-28 WO disclosed